Education
About Us
Working with TipRanks
Follow Us
Edgewell Personal Care (EPC)
NYSE:EPC
Top Page
Edgewell Personal Care
(NYSE:EPC)
Rating:58Neutral
Price Target:
$24.50
▲(11.26% Upside)
Positive Factors
International Market Growth
Strong international growth, with consistent mid- to high single-digit organic growth, indicates expanding market reach and diversification, reducing reliance on North American sales.
Strong Brand Performance
Improved market share for key brands reflects effective brand management and consumer loyalty, supporting long-term revenue stability and competitive positioning.
Productivity and Efficiency Gains
Efficiency improvements and cost savings enhance margin sustainability, providing financial flexibility to invest in growth initiatives and withstand market pressures.
Negative Factors
Decline in North America Sales
Declining sales in North America, driven by volume declines and increased promotions, highlight challenges in a key market, potentially impacting overall revenue and profitability.
Currency and Tariffs Pressures
Currency fluctuations and tariff impacts create cost pressures, reducing profitability and complicating financial planning, especially for international operations.
Lower Earnings and Cash Flow
Decreased cash flow from operations suggests challenges in converting earnings to cash, potentially limiting investment capacity and financial resilience.
Edgewell Personal Care (EPC) vs. SPDR S&P 500 ETF (SPY)
Market Cap
$1.01B
Dividend Yield2.77%
Average Volume (3M)843.05K
Price to Earnings (P/E)16.0
Beta (1Y)0.62
Revenue Growth-2.92%
EPS Growth-43.06%
CountryUS
Employees6,700
SectorConsumer Defensive
Sector Strength42
IndustryHousehold & Personal Products
Share Statistics
EPS (TTM)0.92
Shares Outstanding46,464,245
10 Day Avg. Volume576,007
30 Day Avg. Volume843,049
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market Cap2.30
Enterprise Value/Revenue1.05
Enterprise Value/Gross Profit2.49
Enterprise Value/Ebitda9.44
Forecast
1Y Price Target
$25.81Price Target Upside17.21% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering8
Edgewell Personal Care Business Overview & Revenue Model
Company DescriptionEdgewell Personal Care Company, together with its subsidiaries, manufactures and markets personal care products worldwide. It operates through three segments: Wet shave, Sun and Skin care, and Feminine care. The Wet Shave segment provides razor systems, such as razor handles and refillable blades, and disposable shave products for men and women under the Schick, Wilkinson Sword, Edge, Skintimate, Shave Guard, and Personna brands. The Sun and Skin Care segment provides general protection, sport, kids, baby, tanning and after sun products under the Banana Boat and Hawaiian Tropic brands, as well as antibacterial hand wipes, alcohol sanitizing wipes, and hand sanitizer gels under the Wet Ones brand; and skin care products for men under the Bulldog and Jack Black brands, and skin care and grooming products under the Cremo brand. The Feminine Care segment provides tampons under the Playtex Gentle Glide 360°, Playtex Sport, Playtex and o.b. brands; and markets pads and liners under the Stayfree and Carefree brands. The company was formerly known as Energizer Holdings, Inc. and changed its name to Edgewell Personal Care Company in June 2015. Edgewell Personal Care Company was founded in 1772 and is headquartered in Shelton, Connecticut.
How the Company Makes MoneyEdgewell Personal Care generates revenue primarily through the sale of its consumer products across various retail channels, including mass merchandisers, drugstores, supermarkets, and e-commerce platforms. The company employs a multi-brand strategy, allowing it to capture a broad consumer base by offering a diverse range of products. Key revenue streams include sales of grooming products, which represent a significant portion of their earnings, as well as contributions from feminine care and sun care products. Edgewell also engages in strategic partnerships and collaborations with retailers and distributors to enhance product visibility and availability. Seasonal demand for sun care products further boosts revenues, particularly during the summer months. Additionally, the company's commitment to innovation and product development helps maintain a competitive edge in the market, contributing to its financial growth.
Edgewell Personal Care Earnings Call Summary
Earnings Call Date:Aug 05, 2025
(Q3-2025)
| % Change Since: |
Next Earnings Date:Nov 06, 2025
Earnings Call Sentiment Neutral
The earnings call reflects a mixed sentiment with strong international growth, brand performance, and efficiency gains. However, significant challenges were faced due to adverse weather impacting Sun Care, currency and tariff headwinds, and declining North America sales, resulting in lower earnings and cash flow.Q3-2025 Updates
Positive Updates
International Market Growth
Edgewell's international markets now represent 40% of global sales, collectively delivering consistent mid- to high single-digit organic growth over a 4-year period, with expectations of mid-single-digit organic growth this year.
Strong Brand Performance
Market share performance in the U.S. improved for Hawaiian Tropic, Cremo, and Schick Hydro Silk brands, with Hawaiian Tropic experiencing 150 basis point share growth in Q3.
Productivity and Efficiency Gains
The company delivered almost 300 basis points in gross savings through productivity and efficiency improvements.
Successful Innovation and Expansion
Billie's geographic reach expanded to Australia, Bulldog entered the premium Skin Care category in Europe, and Cremo saw significant benefits from a broadened range in the U.S. and Europe.
Negative Updates
Weak Sun Care Season
Sun Care performance was significantly impacted by adverse weather in North America and Latin America, resulting in a $25 million underperformance in expectations for the quarter.
Currency and Tariffs Pressures
Tariffs and foreign exchange contributed to full-year profit headwinds, with a projected $40 to $50 million annualized impact from tariffs.
Decline in North America Sales
North America organic sales declined by 8%, driven by volume declines and increased promotional levels in Sun Care, Wet Shave, and Fem Care categories.
Lower Earnings and Cash Flow
Net cash provided by operating activities decreased to $44.3 million for the 9 months ended June 30, 2025, down from $157.3 million in the prior year, driven by lower earnings and increased working capital.
Company Guidance
During Edgewell's Third Quarter Fiscal Year 2025 Earnings Call, the company's leadership provided guidance that reflects a challenging quarter with both top and bottom-line performance falling below expectations, primarily due to weak Sun Care sales in North America and Latin America attributed to adverse weather conditions. Despite these challenges, Edgewell reported strong international growth and market share improvements, particularly in Greater China, Europe, and Oceania, contributing to a 2% organic growth internationally. The company highlighted successful brand campaigns, including a notable performance by Hawaiian Tropic with an 18% dollar sales growth and a 150 basis point share gain. The updated full-year outlook anticipates a 1.3% decline in organic net sales, with adjusted earnings per share now projected at approximately $2.65, factoring in $0.46 per share of currency headwinds. Edgewell remains focused on productivity and efficiency, evidenced by a 270 basis point tailwind in the quarter from productivity savings, and plans to continue investing in brand campaigns and operational improvements to bolster future performance. The company also emphasized the strategic importance of its North American transformation efforts and the ongoing commitment to invest in high-return brand initiatives while streamlining operations and mitigating external headwinds such as tariffs and foreign exchange fluctuations.Edgewell Personal Care Financial Statement Overview
Summary
Edgewell Personal Care shows a stable financial position with a robust balance sheet and positive cash flow generation. However, declining revenue growth and pressure on margins are concerns. The company needs to improve operational efficiency and revenue growth.Income Statement
Edgewell Personal Care's income statement shows a mixed performance. The TTM data indicates a decline in revenue growth rate, which is concerning. However, the company maintains a stable gross profit margin of around 42%, and a modest net profit margin of approximately 2.94%. The EBIT and EBITDA margins have decreased compared to previous years, suggesting pressure on operational efficiency.65
Positive
Balance Sheet
The balance sheet reflects a stable financial position with a debt-to-equity ratio of 0.89, indicating manageable leverage. The return on equity has decreased to 4.2% in the TTM period, showing reduced profitability from equity. The equity ratio remains healthy, suggesting a solid capital structure.70
Positive
Cash Flow
Cash flow analysis reveals a positive free cash flow growth rate of 33.44% in the TTM period, which is a strong indicator of cash generation. However, the operating cash flow to net income ratio has decreased, indicating potential challenges in converting income into cash. The free cash flow to net income ratio remains moderate at 36.19%.60
Neutral
| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 2.20B | 2.25B | 2.25B | 2.17B | 2.09B | 1.95B |
| Gross Profit | 929.10M | 955.70M | 940.80M | 879.40M | 951.20M | 880.90M |
| EBITDA | 245.10M | 285.40M | 317.60M | 285.40M | 302.10M | 237.30M |
| Net Income | 64.80M | 98.60M | 114.70M | 99.50M | 117.80M | 67.60M |
Balance Sheet | ||||||
| Total Assets | 3.79B | 3.73B | 3.74B | 3.71B | 3.67B | 3.54B |
| Cash, Cash Equivalents and Short-Term Investments | 199.60M | 209.10M | 216.40M | 188.70M | 479.20M | 364.70M |
| Total Debt | 1.41B | 1.39B | 1.45B | 1.46B | 1.32B | 1.30B |
| Total Liabilities | 2.23B | 2.15B | 2.20B | 2.25B | 2.09B | 2.11B |
| Stockholders Equity | 1.57B | 1.58B | 1.54B | 1.46B | 1.58B | 1.43B |
Cash Flow | ||||||
| Free Cash Flow | 42.70M | 174.50M | 166.60M | 45.60M | 172.20M | 184.90M |
| Operating Cash Flow | 118.00M | 231.00M | 216.10M | 102.00M | 229.00M | 232.60M |
| Investing Cash Flow | -70.80M | -62.40M | -50.50M | -355.40M | -48.70M | -196.40M |
| Financing Cash Flow | -51.00M | -179.40M | -146.50M | -17.60M | -65.40M | -18.70M |
Edgewell Personal Care Technical Analysis
Negative
22.02
Price Trends
24.16
Negative
25.57
Negative
28.72
Negative
Market Momentum
-0.37
Positive
34.32
Neutral
11.95
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For EPC, the sentiment is Negative. The current price of 22.02 is below the 20-day moving average (MA) of 23.19, below the 50-day MA of 24.16, and below the 200-day MA of 28.72, indicating a bearish trend. The MACD of -0.37 indicates Positive momentum. The RSI at 34.32 is Neutral, neither overbought nor oversold. The STOCH value of 11.95 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for EPC.
Edgewell Personal Care Risk Analysis
Edgewell Personal Care disclosed 24 risk factors in its most recent earnings report. Edgewell Personal Care reported the most risks in the "Production" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks
Edgewell Personal Care Peers Comparison
Overall Rating
UnderperformOutperform
Sector (62)
Financial Indicators
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | $570.21M | 5.75 | 13.68% | 2.05% | -11.79% | ― | |
65 Neutral | $3.49B | 21.59 | 20.68% | 2.87% | 7.04% | 13.52% | |
62 Neutral | $20.56B | 14.66 | -3.18% | 3.15% | 1.93% | -6.58% | |
58 Neutral | $1.01B | 16.00 | 4.12% | 2.77% | -2.92% | -43.06% | |
57 Neutral | $1.30B | 20.10 | 2.98% | 3.42% | -2.78% | -17.38% | |
51 Neutral | $567.00M | 5.74 | -23.99% | ― | -4.39% | -326.42% | |
51 Neutral | $2.54B | ― | -8.42% | 4.60% | -5.29% | 9.72% |
* Consumer Defensive Sector Average
Performance Comparison
EPC
Edgewell Personal Care
22.02
-14.69
-40.02%
HELE
Helen Of Troy
24.70
-33.32
-57.43%
IPAR
Inter Parfums
108.53
-6.96
-6.03%
NWL
Newell Brands
6.09
-1.41
-18.80%
NUS
Nu Skin
11.70
4.26
57.26%
SPB
Spectrum Brands Holdings
54.90
-35.45
-39.24%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.